- Filed
- Feb 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 2, 2026 | 13.69M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 13.87M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2024 | 14.21M sh |
| Stock Repurchased | Q1 2026 · Dec 31, 2025 | $5.28M |
| Stock Repurchased | Q1 2026 · Dec 31, 2024 | $6.28M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $82.56M |
| Short Term Investments | Q1 2026 · Sep 30, 2025 | $84.48M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.88M |
| Cash And Equivalents | Q1 2026 · Sep 30, 2025 | $21.49M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $249.65M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $256.16M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $267.44M |
| Stockholders Equity | Q1 2026 · Sep 30, 2024 | $275.76M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $13.21M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $36.6M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $18.4M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $50.01M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $165.74M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $198.49M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $268.05M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $306.17M |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | −$0.04 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | −$0.13 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Dec 31, 2024 | −$0.13 |
| Sga Expense | Q1 2026 · Dec 31, 2025 | $13.21M |
| Sga Expense restated | Q1 2026 · Dec 31, 2024 | $10.72M |
| Net Income | Q1 2026 · Dec 31, 2025 | −$614K |
| Net Income | Q1 2026 · Dec 31, 2024 | −$1.91M |
| Operating Income | Q1 2026 · Dec 31, 2025 | −$1.82M |
| Operating Income restated | Q1 2026 · Dec 31, 2024 | −$2.05M |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $11.39M |
| Gross Profit restated | Q1 2026 · Dec 31, 2024 | $8.68M |
| Cost Of Revenue | Q1 2026 · Dec 31, 2025 | $22.95M |
| Cost Of Revenue restated | Q1 2026 · Dec 31, 2024 | $21.02M |
| Revenue | Q1 2026 · Dec 31, 2025 | $34.34M |
| Revenue restated | Q1 2026 · Dec 31, 2024 | $29.7M |